Therefore, we measured, for the first time in PXE patients and in unaffected subjects (i.e., heterozygous ABCC6 mutation carriers and non-carriers), baseline levels of vitamin K-dependent proteins and -metabolites and their changes after parenteral administration of a single dose of phytomenadione (vitamin K1). The gene discussed is PROS1; the disease is Pseudoxanthoma elasticum.